Abstract | WHAT IS KNOWN AND OBJECTIVE: CASE SUMMARY: WHAT IS NEW AND CONCLUSION:
|
Authors | S Ono, Y Suzuki, M Shindo, T Endo, N Fukui, T Sugai, T Someya |
Journal | Journal of clinical pharmacy and therapeutics
(J Clin Pharm Ther)
Vol. 37
Issue 3
Pg. 370-2
(Jun 2012)
ISSN: 1365-2710 [Electronic] England |
PMID | 22023382
(Publication Type: Case Reports, Journal Article, Review)
|
Copyright | © 2011 Blackwell Publishing Ltd. |
Chemical References |
- Antipsychotic Agents
- Dibenzothiazepines
- Dopamine D2 Receptor Antagonists
- Piperazines
- Quinolones
- Quetiapine Fumarate
- Aripiprazole
|
Topics |
- Adult
- Age Factors
- Akathisia, Drug-Induced
(prevention & control)
- Antipsychotic Agents
(administration & dosage, adverse effects, therapeutic use)
- Aripiprazole
- Dibenzothiazepines
(administration & dosage, therapeutic use)
- Dopamine D2 Receptor Antagonists
- Dose-Response Relationship, Drug
- Drug Monitoring
- Female
- Humans
- Male
- Piperazines
(administration & dosage, adverse effects, therapeutic use)
- Quetiapine Fumarate
- Quinolones
(administration & dosage, adverse effects, therapeutic use)
- Risk Factors
- Schizophrenia
(drug therapy)
- Sex Characteristics
- Treatment Outcome
- Young Adult
|